Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
98 hedge funds and large institutions have $134M invested in Avid Bioservices, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 15 closing their positions.
2,836% more call options, than puts
Call options by funds: $323K | Put options by funds: $11K
50% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 22
45% more capital invested
Capital invested by funds: $92.1M → $134M (+$41.5M)
33% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 15
1% more funds holding
Funds holding: 97 → 98 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
+$6.32M |
| 2 |
AIC
AWM Investment Company
New York
|
+$2.91M |
| 3 |
RA
Royce & Associates
New York
|
+$1.24M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.19M |
| 5 |
BlackRock
New York
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
Roubaix Capital
Denver,
Colorado
|
-$2.08M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.88M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$665K |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$460K |
| 5 |
JP Morgan Chase
New York
|
-$452K |
CDMO Hedge Fund Activity: Q2 2019 in Review
98 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2019, worth a combined $134M — up 45% from $92.1M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CDMO positions and 15 closed out — a net gain of 5 holders — while 33 added to existing stakes and 22 trimmed.
The largest buyer was ISZO Capital Management, adding an estimated $6.32M. The largest seller was Roubaix Capital, exiting entirely with an estimated $2.08M sold.
- 98 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2019, up from 97 in Q1 2019.
- Funds reported $134M of Avid Bioservices, Inc. Common Stock stock for Q2 2019, up 45% quarter-over-quarter.
- 20 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2019 and 15 closed out, a net change of +5 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2019 was ISZO Capital Management, an estimated $6.32M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2019 was Roubaix Capital, an estimated $2.08M sold.
Based on aggregated 13F filings for Q2 2019.